Observational studyDermatologie (Heidelberg, Germany)2026
[Medical care situation of people with vitiligo : A pilot and feasibility study on guideline-oriented management in German dermatology practices].
Observational study in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Vitiligo in Germany : A claims data analysis on prevalence, comorbidity, and treatment patterns].Dermatologie (Heidelberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitiligo is a common chronic disease leading to pigment cell loss in the skin. Despite international consensus recommendations on diagnosis and treatment and the German AWMF S1-guideline published in April 2021, no data exist on the adherence to these recommendations among German dermatologists in private practice. The aim of this pilot project and feasibility study was to obtain preliminary insight into the medical care situation provided by German dermatology practices to people with vitiligo.
methodsIn a cross-sectional observational study, we addressed 572 dermatologists working in German private practices with a questionnaire on attitude, utilized diagnostic procedures, and prescription of reimbursable therapies.
resultsThe majority (53.7%) considered vitiligo a cosmetic problem. Over half (51.1%) of the dermatologists did not use any of the diagnostic methods surveyed, and approximately a quarter (25.6%) did not use any of the therapies surveyed. Dermatologists who regard vitiligo as a serious disease use diagnostic procedures significantly more often and prescribe guideline-based therapies significantly more frequently than those who view vitiligo as a cosmetic issue.
conclusionOur cross-sectional observational and pilot study suggests a dramatic undertreatment of patients with vitiligo in private practices in Germany. Larger and more detailed studies are needed to confirm our preliminary data. In addition, measures that improve guideline-compliant therapy are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.